With new all-time high valuations for the S&P 500 and Nasdaq-100 in full swing, more and more investors are growing wary of buying new names for their portfolios, and for good reason. Buying near the top of the valuation cycle is always a scary thing.
Still, several names haven’t caught up to this optimism today, providing some of the most attractive discounts in the market.
